Inaugural “ATMP world tour”
26 April 2021 - 30 April 2021
Stockholm, Sweden
Advanced Therapy Medicinal Products (ATMPs) represent a fast-moving field of next generation pharmaceuticals, that offer great hope to patients with untreatable or incurable disease. The use of cells or genes in medicines is already transforming disease treatment with patients benefitting from ‘one time’ ATMP treatments like life-saving CAR T treatments and curative gene correction therapies.
The “ATMP world tour” is the first event of its kind internationally. The event aims to accelerate ATMP solutions for patients in Sweden and internationally by gathering international strength and driving knowledge exchange around successful development models. The event focuses on partnerships, infrastructures and competences, all essential aspects of a field requiring unprecedented interactions between stakeholders.
Hosted by Sweden’s cell and gene therapy product network “ATMP Sweden”, this inaugural ATMP world tour was inspired by the ‘no travel’ restriction of the pandemic. The program values dialogue over monologue, a unique and refreshing change to the current excess of one-way online speeches. The event is online and free to register.
Find more information including registration on our website https://atmpsweden.se/atmpconference/atmp-world-tour-2021/(opens in new window)
The 5 half-days program (26th till 30th April 2021) hosts 20 speakers from 14 countries on 4 continents, all carefully selected as high-profile international experts in various aspects of ATMP development. The presentations exhibit successful models that have contributed to bringing these complex pharmaceuticals to patients around the world and are targeted to an audience active in relevant challenges. Each speaker is partnered with a Swedish expert to drive a high level one on one discussion session and inspire interactive Q&A.
See the full program here https://atmpsweden.se/atmpconference/atmp-world-tour-2021/program/(opens in new window)
World renowned international speakers include John Rasko, former ISCT president and Robert Klein, leader of California’s Proposition 71 and founding Chair of the 3 billion USD Centre for Regenerative Medicine (CIRM). World renowned organisations in the program include speakers from the UK Cell and Gene Therapy Catapult, Centre for Commercialization of Regenerative Medicine (CCRM) Americans for cures, FIRM, Cytiva, ARM, Novo Nordisk, CARM/SCRM Korea and Celgene/BMS.
The “ATMP world tour” is the first event of its kind internationally. The event aims to accelerate ATMP solutions for patients in Sweden and internationally by gathering international strength and driving knowledge exchange around successful development models. The event focuses on partnerships, infrastructures and competences, all essential aspects of a field requiring unprecedented interactions between stakeholders.
Hosted by Sweden’s cell and gene therapy product network “ATMP Sweden”, this inaugural ATMP world tour was inspired by the ‘no travel’ restriction of the pandemic. The program values dialogue over monologue, a unique and refreshing change to the current excess of one-way online speeches. The event is online and free to register.
Find more information including registration on our website https://atmpsweden.se/atmpconference/atmp-world-tour-2021/(opens in new window)
The 5 half-days program (26th till 30th April 2021) hosts 20 speakers from 14 countries on 4 continents, all carefully selected as high-profile international experts in various aspects of ATMP development. The presentations exhibit successful models that have contributed to bringing these complex pharmaceuticals to patients around the world and are targeted to an audience active in relevant challenges. Each speaker is partnered with a Swedish expert to drive a high level one on one discussion session and inspire interactive Q&A.
See the full program here https://atmpsweden.se/atmpconference/atmp-world-tour-2021/program/(opens in new window)
World renowned international speakers include John Rasko, former ISCT president and Robert Klein, leader of California’s Proposition 71 and founding Chair of the 3 billion USD Centre for Regenerative Medicine (CIRM). World renowned organisations in the program include speakers from the UK Cell and Gene Therapy Catapult, Centre for Commercialization of Regenerative Medicine (CCRM) Americans for cures, FIRM, Cytiva, ARM, Novo Nordisk, CARM/SCRM Korea and Celgene/BMS.
Keywords
ATMP, ATMP Sweden, cell therapy, gene therapy, Advanced Therapies, ATMP world tour